U.S. Tech Hardware Stock News

In recent days, Dynatrace highlighted its expanding role in AI-powered observability through CEO commentary on “extraordinary growth” following an AWS milestone, while executives also appeared at a major Morgan Stanley technology conference and new analyst coverage was initiated alongside reaffirmed positive ratings. These developments collectively emphasize how accelerating enterprise interest in AI-driven observability and cloud optimization is reinforcing Dynatrace’s position within the...

If you are wondering whether Sterling Infrastructure's share price still offers value after a strong run, this article will walk through how that question stacks up against the numbers. The stock recently closed at US$428.13, with returns of 14.6% over the last 30 days, 34.1% year to date, 236.6% over 1 year and a very large gain over 5 years. Recent coverage of Sterling Infrastructure has focused on its role in capital projects and how investor attention has shifted toward companies...

If you are wondering whether Antero Resources at around US$36.81 is giving you enough value for the risk you take, you are not alone. This review is built to help you frame that question clearly. The stock has posted returns of 3.6% over 7 days, 4.3% over 30 days, 7.6% year to date and 0.3% over 1 year, while its 3 year return sits at 34.8% and its 5 year return is described as very large. Recent coverage around Antero Resources has focused on its position within the US energy sector and how...

Morningstar (NasdaqGS:MORN) has launched Foundation Series Collective Investment Trusts in collaboration with Alta Trust Company and several large asset managers. The new CITs focus on providing retirement plans with broader access to institutional investment solutions with an emphasis on simplicity and diversification. Morningstar has also appointed Scott Brown as President of Direct Platform, with a remit to accelerate product development and data platform work. Morningstar, known for its...

If you are wondering whether Payoneer Global's current share price reflects its true worth, this article walks through what the numbers are actually saying about value. The stock last closed at US$4.32, after returns of a 20.1% decline over the past week, a 31.4% decline over the past month, a 20.6% decline year to date and a 49.5% decline over the past year. Recent share price moves come against a backdrop of ongoing interest in digital cross border payments and financial infrastructure for...

Recent analyst upgrades and steady upward revisions to earnings estimates have put Five Below (FIVE) in focus, as investors weigh how stronger sentiment and ongoing store openings might influence the stock’s risk and return profile. See our latest analysis for Five Below. The share price has been moving sharply, with a 20.55% 1 month share price return and a 35.56% 3 month share price return. The 1 year total shareholder return of about 157% points to strong momentum around store openings and...

In February 2026, Garmin reported fourth-quarter 2025 sales of US$2,124.96 million and net income of US$528.68 million, alongside full-year 2025 sales of US$7.25 billion and net income of US$1.66 billion, while proposing a higher US$4.20 per-share dividend and completing a US$244.60 million buyback under its prior repurchase plan. Management also issued 2026 guidance calling for US$7.90 billion in revenue and operating income above US$2.00 billion, launched new high-end motorsports and...

PACS Group (PACS) just wrapped up FY 2025 with Q4 revenue of US$1.4b and basic EPS of US$0.38, supported by trailing twelve month revenue of US$5.3b and EPS of US$1.23 that has been tied to very large year on year earnings growth of 243.5%. Over recent periods, the company has seen quarterly revenue move from US$1.21b in Q4 2024 to US$1.36b in Q4 2025, while quarterly EPS went from US$0.24 to US$0.38. This sets up a results season where strong reported earnings growth, margin improvement to...

ADMA Biologics (ADMA) shares are in focus after the company paired strong 2025 revenue and earnings with reaffirmed multi year guidance, yield focused operational changes, and a CFO transition aimed at supporting execution. See our latest analysis for ADMA Biologics. At a share price of US$15.57, ADMA has seen a 1 day share price return of 2.57%. However, the 30 day and year to date share price returns of 8.47% and 12.92% declines suggest recent momentum has cooled. This follows a very large...

Turning Point Brands (NYSE:TPB) announces a 7% increase in its quarterly dividend. The company introduces Stoker's Proud, a new value-focused tobacco sub-brand. Both updates highlight TPB's focus on shareholder returns and a broader product lineup. Turning Point Brands, known for its tobacco and related products, is adding fresh headlines for shareholders with a higher quarterly dividend and a new offering in its Stoker's family. The move comes as value focused products remain an important...

GeneDx Holdings (NasdaqGS:WGS) Chief Operating Officer Bryan Dechairo has sold his entire direct shareholding in an open market transaction. The sale was executed under a Rule 10b5-1 trading plan and leaves Dechairo with no direct equity interest in the company. This insider transaction comes as GeneDx continues to report business growth and operational progress. The move comes at a time when GeneDx shares last closed at $79.71, with the stock showing mixed performance across time frames...

Warner Bros. Discovery (WBD) has capped FY 2025 with fourth quarter revenue of US$9.5b and a basic EPS loss of US$0.10, setting the tone for a year where profitability on a trailing basis has been supported by a sizeable one off gain. The company has seen quarterly revenue range between US$9.0b and US$9.8b across 2025, with EPS swinging from a loss of US$0.18 in Q1 to a profit of US$0.64 in Q2 before reverting to losses in Q3 and Q4. This leaves investors focusing on how much of the reported...

Charles Schwab (NYSE:SCHW) is moving to acquire Forge Global Holdings to expand its private market offerings. The deal is intended to give Schwab clients access to a broader range of private company investments. At the same time, new AI tools such as Altruist's AI powered tax product are increasing technology pressure across wealth management. For you as an investor, this combination of events ties directly to how Schwab positions itself in wealth management and trading. The firm already...

BrightSpring Health Services (BTSG) just closed FY 2025 with fourth quarter revenue of US$3.6b and basic EPS of US$0.24, while net income from continuing operations, excluding extra items, came in at US$49.3m. The company has seen quarterly revenue move from US$3.1b and EPS of US$0.08 in Q4 2024 to US$3.6b and EPS of US$0.24 in Q4 2025, with trailing twelve month EPS at US$0.53 and net income of US$106.3m on US$12.9b in revenue. This puts the latest report firmly in focus for anyone tracking...

ESAB (NYSE:ESAB) has introduced the Ruffian EMP 270G engine-driven welding generator at CONEXPO-CON/AGG 2026. The unit features advanced inverter technology and more than 100 customer-requested features. The product was developed in collaboration with Linde, with exclusive offerings tied to the trade show launch. ESAB, listed on the NYSE under the ticker ESAB, is a welding and cutting equipment company with a focus on industrial and construction applications. By rolling out the Ruffian EMP...

Iovance Biotherapeutics recently reported Q4 2025 and full-year 2025 results, with revenue rising to US$86.77 million for the quarter and US$263.50 million for the year, alongside lower quarterly net loss and loss per share compared with 2024. At the same time, the company highlighted positive early lifileucel data in aggressive soft tissue sarcomas and secured FDA Fast Track designation for non-small cell lung cancer, underscoring how its first commercial TIL therapy Amtagvi is increasingly...

Earlier this month, Ecolab’s board reshaped its senior team by adding the President title to Chairman and CEO Christophe Beck and splitting the chief operating officer role between Darrell R. Brown as Co-COO – Global Markets and Gregory B. Cook as Co-COO – Global Businesses, while director Victoria J. Reich decided not to stand for re-election and the company affirmed its US$0.73 quarterly dividend. These leadership changes, alongside a new shelf registration for debt securities, suggest...

Applied Optoelectronics (AAOI) closed out FY 2025 with fourth quarter revenue of US$134.3 million and a basic EPS loss of US$0.03, alongside net income excluding extra items of a US$2.0 million loss. This puts the focus squarely on how efficiently that top line is being converted into earnings. The company has seen quarterly revenue move from US$65.2 million in Q3 2024 to US$100.3 million in Q4 2024, then to US$99.9 million in Q1 2025, US$103.0 million in Q2 2025, US$118.6 million in Q3 2025...

Perella Weinberg Partners recently reported quarterly revenues of US$219.2 million, a 2.9% year-on-year decline that still exceeded analyst estimates by a very large margin, alongside an earnings beat. The results highlight how the firm’s operational execution outpaced expectations even as headline revenue slipped, offering a more nuanced picture of performance for investors. Next, we’ll examine how this better-than-expected revenue performance shapes Perella Weinberg Partners’ investment...

Short term moves and recent performance context Berkshire Hathaway (BRK.A) recently closed at US$757,000, with the stock showing a 0.5% move over the past day and a 1.4% gain across the past week, keeping short term performance in focus for investors. See our latest analysis for Berkshire Hathaway. That recent 6% 1 month share price return comes after a softer 90 day share price return of a 1.7% decline and sits alongside a 3 year total shareholder return of about 60%. This suggests longer...

In the fourth quarter and full year ended December 31, 2025, Jones Lang LaSalle reported higher sales and net income year over year, while also completing a multi‑year share repurchase program totaling 6.80 million shares for US$1.40 billion since its November 2019 authorization. The combination of earnings exceeding analyst expectations and management’s plan to direct more capital toward buybacks in 2026 highlights a greater emphasis on capital return alongside operational growth in...

Community Trust Bancorp recently highlighted a quarterly dividend of US$0.53 per share, implying a 3.43% yield and reflecting five consecutive years of annual dividend increases averaging 5.32%. Alongside this dividend profile, the company is guided by a Zacks Consensus Estimate pointing to fiscal 2026 earnings of US$5.79 per share, suggesting investors are closely watching how income and earnings trends align. With this backdrop of consistent dividend growth, we’ll examine how the company’s...

Synopsys (NasdaqGS:SNPS) has appointed Peter A. Shimer, a long time Deloitte executive, to its board of directors and audit committee. The company is not renominating two sitting directors, resulting in a refreshed board composition. Shimer brings extensive financial, operational and AI related governance experience, including work with AI focused cancer research alliances. For investors watching Synopsys at a share price of $414.0, this board change arrives after mixed recent returns. The...

In February 2026, STAAR Surgical announced that the FDA approved an expanded age indication for its EVO/EVO+ Visian Implantable Collamer Lenses, extending U.S. use from ages 21–45 to 21–60 following three-year safety data. This broader label meaningfully enlarges the potential U.S. candidate pool for EVO ICL, especially among adults aged 46–60 who were previously excluded. We’ll now examine how opening EVO ICL access to patients up to age 60 could reshape STAAR Surgical’s longer-term...